Navigation Links
New technique identifies pathogens in patient samples faster, in great detail
Date:12/2/2013

A team of Danish investigators has shown how to identify pathogens faster, directly from clinical samples. The research, published online ahead of print in the Journal of Clinical Microbiology appears in the journal's January 2014 issue.

The investigators used a technique known as whole genome sequencing to identify and completely characterize bacteria causing urinary tract infections. In just 18 hours, they identified the culprit microorganisms, characterized the pathogens' patterns of antibiotic susceptibility, and identified specific strains.

"Using conventional methodologies this would have taken several days to weeks, and even using whole genome sequencing on cultured bacteria would have taken an extra day," says Frank M. Aarestrup of the Technical University of Denmark, Lyngby, an author on the study.

Their work will help patients heal more quickly and avoid unnecessarily prolonged illness and even death. It will also help prevent outbreaks of hospital-acquired disease, and identify emerging infections.

"Rapid identification of the causative agent, and of any antibiotic resistance is crucial to choosing the correct treatment for individual patients," says Aarestrup. "Choosing the wrong antibiotic will lead to longer infections and in the worst case, deaths."

The investigators also identified bacteria in the patient samples that they did not detect using conventional techniques. "Lactobacillus iners, Gardnerella vaginalis, Prevotella, and A. urinae have all been implicated in [urinary tract infections], even though their precise roles as pathogens and normal colonizers of the genital tract have not been firmly established," write the researchers. They note that by conventional methods A. urinae is rarely identified but frequently misclassified.

The ability to identify strains in patients with repeated infections enables the doctor to know whether the patient's infection is new, or recurrent. And the typing of bacterial strains enables rapid comparison of bacteria from different patients, so that doctors can detect the spread of infections within the hospital, and identify emerging infections.

"Whole genome sequencing may still be too expensive for routine use in most clinical microbial laboratories," the researchers write. But they predict that rapidly falling prices and automation will render it a standard technology for infection detection and control, in and out of the hospital.


'/>"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
Source:Eurekalert

Related biology news :

1. Integrated pest managment techniques can help manage the Bagrada bug
2. New technique for testing drugs to treat cystic fibrosis and epilepsy
3. UT Dallas computer scientists create 3-D technique
4. New technique controls dimensions of gold nanorods while manufacturing on a large scale
5. New technique for developing drugs to treat serious illnesses
6. Novel technique for suturing tissue-engineered collagen graft improves tendon repair
7. EUREKA grant to fund development of new optogenetic technique for mapping neural networks at UMMS
8. Research reveals bottom feeding techniques of tagged humpback whales in Stellwagen Bank Sanctuary
9. New technique for measuring tree growth cuts down on research time
10. New gene repair technique promises advances in regenerative medicine
11. First child born following embryo screening with new genome analysis technique
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2017)... -- Research and Markets has announced the ... Scientific and Commercial Aspects" to their offering. ... Biomarkers play ... therapy for selection of treatment as well for monitoring the ... disease in modern medicine. Biochip/microarray technologies and next generation sequencing ...
(Date:2/8/2017)...  Aware, Inc. (NASDAQ: AWRE ), a leading ... for its quarter and year ended December 31, 2016. ... $3.9 million compared to $6.9 million in the same quarter ... was $0.6 million compared to $2.6 million in the fourth ... 2016 was $0.5 million, or $0.02 per diluted share, which ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... billion by 2021 from $8.3 billion in 2016 at ... 2016 to 2021. Report Includes - An overview ... global market trends, with data from 2015 and 2016, ... 2021. - Segmentation of the market on the basis ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... FRANCISCO , Feb. 23, 2017   ViaCyte, ... Type 1, a not-for-profit advocacy and education group for ... grant from Beyond Type 1 to support ViaCyte,s efforts ... other insulin-requiring diabetes.  For more than ... cell replacement therapies with a focus on the treatment ...
(Date:2/22/2017)... Feb. 22, 2017  PrimeVax Immuno-Oncology, Inc. announced today ... at the Annual Biocom Global Life Science Partnering Conference.  ... 11:15 AM, at the Torrey Pines Lodge, in San ... organizers at Biocom who have chosen our company, amongst ... biotechnology companies, investors, and clinical researchers," said Mr. Chen. ...
(Date:2/22/2017)... ... ... LabRoots , the leading provider of educational and interactive virtual events ... the launch of a new scholarship for young scientists seeking a degree in any ... open to all high school seniors, 17 years or older; as well as those ...
(Date:2/22/2017)... ... February 22, 2017 , ... Pharma and ... Perkins as European director. Operating from Pennside’s Zurich headquarters, Pennside Partners, GmbH, Mr. ... joins Pennside after more than a decade with leading market research firm, GfK. ...
Breaking Biology Technology: